Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110247222> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2110247222 endingPage "2202" @default.
- W2110247222 startingPage "2191" @default.
- W2110247222 abstract "Aggressive antiplatelet treatment is currently an established practice in patients with coronary artery disease.This article discusses the evidence from clinical trials and registries concerning the benefits and risks of clopidogrel in relation to the dose and timing of treatment and its use in particular patient populations (stratified by risk factors for major adverse cardiovascular events).Human clinical trials, registries, and in vitro human platelet studies were identified through searches of MEDLINE, Scopus, Google Scholar, and ClinicalTrials.gov (January 1980-July 2008) using the terms clopidogrel in coronary artery disease, clopidogrel loading dose, clopidogrel pretreatment, and antiplatelet therapy for coronary artery disease. For inclusion in the review, publications had to compare clopidogrel administered at different doses and times across the spectrum of patients with coronary artery disease; present outcome data on mortality, reinfarction, stroke, or their combination; and report safety data pertaining to bleeding risk.The results of randomized trials support the benefit of administering a 300-mg loading dose of clopidogrel as part of both conservative and invasive strategies for the management of acute coronary syndromes (ACS). In a small randomized trial in patients with non-ST-segment elevation ACS, pretreatment with clopidogrel 600 mg >12 hours before coronary stenting was associated with significantly fewer major adverse cardiovascular events compared with pretreatment with clopidogrel 300 mg (P = 0.020). A randomized trial in patients with ACS undergoing percutaneous coronary intervention (PCI) reported a significant reduction in ischemic risk with prasugrel (60-mg loading dose, 10-mg/d maintenance dose) compared with clopidogrel (300-mg loading dose, 75-mg/d maintenance dose) (P < 0.001); however, the clinical benefit with prasugrel was accompanied by a significant increase in the risk of life-threatening bleeding (P = 0.01). Pretreatment with a 300-mg clopidogrel loading dose administered at least 15 hours before elective PCI was associated with a significant reduction in periprocedural ischemic events compared with 75 mg given after PCI (P = 0.028). In another randomized trial in patients undergoing elective PCI, pretreatment with clopidogrel 600 mg before diagnostic catheterization was associated with a significantly increased risk of minor bleeding complications (P = 0.027) without a significant benefit in terms of the primary ischemic end point. Data from registries support the use of a 300-mg loading dose of clopidogrel for the standard care of patients with ACS and indicate no significant benefit for pretreatment with loading doses >300 mg. One study of registry data found that pretreatment with clopidogrel 300 mg before elective PCI was associated with a significant reduction in major adverse cardiovascular events compared with a loading dose given immediately before or after the intervention (P = 0.002).Suppression of platelet activity through the use of antithrombotic agents should be balanced against the risk of atherothrombotic events. In patients with ACS, inhibition of platelet activation beyond that produced by clopidogrel 600 mg has been associated with an increased bleeding risk. In patients undergoing elective PCI, pretreatment with clopidogrel 300 mg administered >15 hours before the procedure achieved the optimal risk-benefit ratio. In cases of unplanned PCI, administration of clopidogrel 600 mg immediately after diagnostic catheterization was well tolerated and effective." @default.
- W2110247222 created "2016-06-24" @default.
- W2110247222 creator A5057812039 @default.
- W2110247222 creator A5068530505 @default.
- W2110247222 date "2008-01-01" @default.
- W2110247222 modified "2023-09-27" @default.
- W2110247222 title "Benefits and risks of clopidogrel use in patients with coronary artery disease: Evidence from randomized studies and registries" @default.
- W2110247222 cites W1553345686 @default.
- W2110247222 cites W1941211279 @default.
- W2110247222 cites W1982658190 @default.
- W2110247222 cites W2000588400 @default.
- W2110247222 cites W2001554000 @default.
- W2110247222 cites W2001688139 @default.
- W2110247222 cites W2002311059 @default.
- W2110247222 cites W200979310 @default.
- W2110247222 cites W2021646089 @default.
- W2110247222 cites W2024352468 @default.
- W2110247222 cites W2040481489 @default.
- W2110247222 cites W2041694866 @default.
- W2110247222 cites W2041936661 @default.
- W2110247222 cites W2053379248 @default.
- W2110247222 cites W2054371088 @default.
- W2110247222 cites W2060295200 @default.
- W2110247222 cites W2075358198 @default.
- W2110247222 cites W2083038715 @default.
- W2110247222 cites W2099085329 @default.
- W2110247222 cites W2100209149 @default.
- W2110247222 cites W2104549091 @default.
- W2110247222 cites W2107797912 @default.
- W2110247222 cites W2116166586 @default.
- W2110247222 cites W2124046264 @default.
- W2110247222 cites W2134124835 @default.
- W2110247222 cites W2147746835 @default.
- W2110247222 cites W2152823642 @default.
- W2110247222 cites W2165847629 @default.
- W2110247222 cites W2169387542 @default.
- W2110247222 cites W2232858378 @default.
- W2110247222 cites W2394857390 @default.
- W2110247222 cites W2436889673 @default.
- W2110247222 cites W2162886638 @default.
- W2110247222 doi "https://doi.org/10.1016/j.clinthera.2008.12.001" @default.
- W2110247222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19281914" @default.
- W2110247222 hasPublicationYear "2008" @default.
- W2110247222 type Work @default.
- W2110247222 sameAs 2110247222 @default.
- W2110247222 citedByCount "9" @default.
- W2110247222 countsByYear W21102472222012 @default.
- W2110247222 countsByYear W21102472222016 @default.
- W2110247222 countsByYear W21102472222019 @default.
- W2110247222 countsByYear W21102472222022 @default.
- W2110247222 crossrefType "journal-article" @default.
- W2110247222 hasAuthorship W2110247222A5057812039 @default.
- W2110247222 hasAuthorship W2110247222A5068530505 @default.
- W2110247222 hasConcept C126322002 @default.
- W2110247222 hasConcept C164705383 @default.
- W2110247222 hasConcept C168563851 @default.
- W2110247222 hasConcept C197934379 @default.
- W2110247222 hasConcept C2777028646 @default.
- W2110247222 hasConcept C2777698277 @default.
- W2110247222 hasConcept C2777849778 @default.
- W2110247222 hasConcept C2778213512 @default.
- W2110247222 hasConcept C2780400711 @default.
- W2110247222 hasConcept C35294091 @default.
- W2110247222 hasConcept C500558357 @default.
- W2110247222 hasConcept C535046627 @default.
- W2110247222 hasConcept C71924100 @default.
- W2110247222 hasConceptScore W2110247222C126322002 @default.
- W2110247222 hasConceptScore W2110247222C164705383 @default.
- W2110247222 hasConceptScore W2110247222C168563851 @default.
- W2110247222 hasConceptScore W2110247222C197934379 @default.
- W2110247222 hasConceptScore W2110247222C2777028646 @default.
- W2110247222 hasConceptScore W2110247222C2777698277 @default.
- W2110247222 hasConceptScore W2110247222C2777849778 @default.
- W2110247222 hasConceptScore W2110247222C2778213512 @default.
- W2110247222 hasConceptScore W2110247222C2780400711 @default.
- W2110247222 hasConceptScore W2110247222C35294091 @default.
- W2110247222 hasConceptScore W2110247222C500558357 @default.
- W2110247222 hasConceptScore W2110247222C535046627 @default.
- W2110247222 hasConceptScore W2110247222C71924100 @default.
- W2110247222 hasLocation W21102472221 @default.
- W2110247222 hasLocation W21102472222 @default.
- W2110247222 hasOpenAccess W2110247222 @default.
- W2110247222 hasPrimaryLocation W21102472221 @default.
- W2110247222 hasRelatedWork W2134537267 @default.
- W2110247222 hasRelatedWork W2184973323 @default.
- W2110247222 hasRelatedWork W2213039457 @default.
- W2110247222 hasRelatedWork W2325312573 @default.
- W2110247222 hasRelatedWork W2473576731 @default.
- W2110247222 hasRelatedWork W2979957865 @default.
- W2110247222 hasRelatedWork W3003059809 @default.
- W2110247222 hasRelatedWork W3134665543 @default.
- W2110247222 hasRelatedWork W68793142 @default.
- W2110247222 hasRelatedWork W2072549250 @default.
- W2110247222 hasVolume "30" @default.
- W2110247222 isParatext "false" @default.
- W2110247222 isRetracted "false" @default.
- W2110247222 magId "2110247222" @default.
- W2110247222 workType "article" @default.